Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Kawachi Pharmaceutical reported consolidated results for April–September 2026, with net profit down 9% year over year to ¥2.2 billion, revenue down 1% to ¥144.1 billion, and operating profit down 6% to ¥3.0 billion.2d agoKawachi Limited reported consolidated ordinary profit of ¥3.46 billion for the six months ended September 2026, down 8.9% year over year; second-quarter ordinary profit fell 19.9% to ¥1.75 billion and the operating margin declined to 2.2% from 2.6%.2d agoKawachi Yakuhin, in partnership with Tochigi Prefecture and Otsuka Pharmaceutical, will run the 'Tochimaru Health Points Autumn Health Support Campaign' at 82 stores in Tochigi Prefecture from October 10 to November 11, 2026.24d ago